Nodexus

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

Operating in health based in Silicon Valley, California, Nodexus operates.

Profile

"Nodexus is a pioneering health startup focused on democratizing access to live single cells for various applications, including gene editing and drug development. Developed at Princeton University and UC Berkeley, Nodexus has created a groundbreaking microfluidic technology that enhances the detection of circulating tumor cells (CTCs) responsible for cancer metastasis. Their patented platform is cost-effective, portable, and requires minimal sample preparation, delivering rapid and precise results. Unlike existing systems, Nodexus can identify various types of CTCs, revolutionizing cancer diagnostics. By shifting towards predictive and personalized medicine, Nodexus aims to empower healthcare professionals with real-time information for prompt treatment decisions. This innovative approach eliminates the delays associated with traditional diagnostic testing, ultimately improving patient outcomes."

As a business in health, Nodexus is listed here with the public details available about it.

The company is recorded as being based in Silicon Valley, California.

The company is listed at the Plug and Play portfolio startup stage of development.

Website: www.nodexus.com